Track topics on Twitter Track topics that are important to you
Novocure Ltd. (developed the Tumor Treating Fields alternating electrical field technology to treat cancer) entered into a $150mm non-dilutive term loan with BioPharma Credit PLC (managed by Pharmakon...
So hätten sich die beiden Unternehmen geeinigt, bis zu zehn klinische Studienprogramme in den kommenden drei Jahren zu starten, die auf eine verstärkte Dezentralisierung setzen, teilt der Pharmakon....
A term loan agreement was reached by Novocure with BioPharma Credit, the investment fund of Pharmakon Advisors, for a term lo -More-
Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs into the market and obstructing the US FDA’s lawful fu...
Tesaro Inc. (cancer therapeutics) entered into a $500mm term loan agreement with Biopharma Credit PLC and Biopharma Credit Investments IV (both managed by Pharmakon Advisors). Tesaro will draw down th...
Lexicon Pharmaceuticals Inc. (gene-targeting therapies for diabetes, carcinoid syndrome, and neuropathic pain) entered into a $200mm non-dilutive term loan agreement with Biopharma Credit PLC and Biop...
We have published hundreds of AIM Pharmakon, Inc. news stories on BioPortfolio along with dozens of AIM Pharmakon, Inc. Clinical Trials and PubMed Articles about AIM Pharmakon, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AIM Pharmakon, Inc. Companies in our database. You can also find out about relevant AIM Pharmakon, Inc. Drugs and Medications on this site too.